Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Use this CSBR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CSBR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CSBR SEC filings page. Lician reads the product cache first so this HTML stays unique to Champions Oncology Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CSBR income, balance, and cash tables.